The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies.

Main|Search|PHGKB

Last Posted: Sep 15, 2017

---

• Opioid crisis adds to pain of sickle cell patients  
• Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease: a Review.  
  Nickel Robert Sheppard et al. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017 Sep
• The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies.  
  McGann Patrick T et al. Blood cells, molecules & diseases 2017 Aug
• Application of genomics for transfusion therapy in sickle cell anemia.  
  Chou Stella T et al. Blood cells, molecules & diseases 2017 Aug
• Newborn screening for sickle cell disorders using tandem mass spectrometry: three years' experience of using a protocol to detect only the disease states.  
  Moat Stuart J et al. Annals of clinical biochemistry 2017 Sep 54(5) 601-611
• Trends and patterns of mortality associated with birth defects and genetic diseases in the United States, 1979-1992: an analysis of multiple-cause mortality data.  
  Yang Q et al. Genetic epidemiology 1997 14(5) 493-505
• Living Well with Sickle Cell Disease 
• Management of iron overload in hemoglobinopathies.  
  Allali S et al. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2017 Jun
• Thalassaemia.  
  Taher Ali T et al. Lancet (London, England) 2017 Jul
• Awareness of Sickle Cell Trait Status: A Cross-Sectional Survey of Antenatal Women in Ghana.  
  Obed Samuel Amenyi et al. The American journal of tropical medicine and hygiene 2017 Mar 96(3) 735-740
• FDA approves new treatment for sickle cell disease First approval for this rare blood disorder in nearly 20 years  
• Neonatal screening improves sickle cell disease clinical outcome in Belgium.  
  Lê Phu-Quoc et al. Journal of medical screening 2017 Jan 969141317701166
• Personal Foul? Many issues, from discrimination to cost, surround the NCAA requirement for sickle cell trait testing in college athletes.  
  L Biel, Genome Magazine, July 2017
• FDA approves new treatment for sickle cell disease First approval for this rare blood disorder in nearly 20 years  
• The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial.  
  Nimmer Mark et al. Pediatric blood & cancer 2016 Sep 63(9) 1649-52
• Sickle Cell Disease in the Emergency Department: Confronting Barriers to Care 

more